EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives $26.63 Average Target Price from Analysts
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has received a consensus rating of “Buy” from the nine ratings firms that are presently covering the stock, MarketBeat reports. Nine analysts have rated the stock with a buy recommendation. The average 1 year price target among brokers that have updated their coverage on the stock in […]
EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report) has received a consensus rating of “Buy” from the nine ratings firms that are presently covering the stock, MarketBeat reports. Nine analysts have rated the stock with a buy recommendation. The average 1 year price target among brokers that have updated their coverage on the stock in […]
